Provider
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Program effective Date: Dec 20, 2016
Documents & Forms Results
Displaying 2991 - 3000 of 3102 results
Provider
QP39-16 Digital Breast Tomosynthesis (DBT) for Routine Breast Cancer Screening
Program effective Date: Dec 15, 2016
Provider
QP40-16 Medicare Outpatient Observation Notice (MOON) CMS-10611
Program effective Date: Dec 15, 2016
Provider
QP42-16 Pharmacy Step Therapy Program Name Change for Anticonvulsant Agents and Update on Drugs Subject to This Step Therapy Program
Program effective Date: Dec 15, 2016
Provider
QP41-16 Quality Improvement Information Available in Provider Press Publication
Program effective Date: Dec 15, 2016
Provider
QP38-16 Update on Car and Booster Seat Program for PMAP and MinnesotaCare Subscribers
Program effective Date: Dec 13, 2016
Provider
P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess
Program effective Date: Dec 13, 2016
Provider
P62-16 EY Modifier for Platinum Blue Subscribers
Program effective Date: Dec 13, 2016
Provider
P60-16 New Drug-Related Prior Authorization Criteria with Quanatity Limit for Topical Diclofenac Gel, Fluorourcil Cream, Imquimod Cream and Ingenol Gel
Program effective Date: Dec 13, 2016
Provider
QP37-16 Difference in Operating Systems Identified - GY Modifier
Program effective Date: Dec 09, 2016